Defining new ground for the treatment of schizophrenia

Abstract

Unravelling the family of neurotransmitters involved in schizophrenia and locating their receptors is allowing researchers to develop new drugs that are likely to have a major impact on the treatment of schizophrenia and other psychiatric diseases. At the Third International Conference on Schizophrenia entitled ‘Schizophrenia 1994: Exploring the Spectrum of Psychosis’ [Vancouver, Canada; August 1994] several key speakers outlined possible new approaches to the treatment of this condition.